GLPwatch
Trials (2083)
Page 31 of 35.
- STEP 6: Research Study Investigating How Well Semaglutide Works in People Living With Overweight or Obesity
- The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
- A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
- A Study of Tirzepatide in Overweight and Very Overweight Participants
- Comparison of Type 2 Diabetes Pharmacotherapy Regimens
- Safety and Efficacy of Liraglutide in Parkinson's Disease
- Biomarkers in Obese Patients With Knee Osteoarthritis; Weight Loss
- Epidemiological Assessment of the Risk for Pancreatic Cancer Associated With the Use of Semaglutide in Patients With Type 2 Diabetes - A Cohort Study Based on Nordic Registry Data
- Does Treatment With GLP-1 Reduce Alcohol Intake in Patients With Alcohol Dependence?
- Relationship Between Improvement in Insulin Secretion and Decrease in HbA1c in GLP-1 RA Therapy in T2DM Patients
- The Microvascular Function of GLP-1 and Its Analogues
- Combined Effects of GLP-1 Analogue and Exercise on Maintenance of Weight Loss and Health After Very-low Calorie Diet
- A Study of LY3457263 Alone and in Combination With Dulaglutide (LY2189265) in Participants With Type 2 Diabetes
- Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
- Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell Mass
- Feasibility Study of Exenatide by Continuous Subcutaneous Infusion
- A Long-term Trial to Compare the Effects of Liraglutide and Sulphonylurea (Glimepiride) Both in Combination With Metformin on Clinical, Endothelial and Image Markers of Cardiovascular Risk in Patients With Type 2 Diabetes
- Comparison of the Effect of Liraglutide in Young Versus Elderly Healthy Volunteers
- Semaglutide for Alcohol Use Disorder
- A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus in India
- GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV
- Obstructive Sleep Apnea Master Protocol GPIF: A Study of Tirzepatide (LY3298176) in Participants With Obstructive Sleep Apnea
- How Glargine Insulin, Oral Diabetes Medications and Exenatide May Improve Blood Sugar Control and Weight Gain in Type 2 Diabetics
- A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting
- Evaluation of the Safety and Efficacy of Revita® DMR on Body Weight Maintenance in Subjects With Obesity Who Have Achieved at Least 15% Weight Loss on Tirzepatide
- A Study of LY2189265 in Japanese Patients With Type 2 Diabetes
- Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA)
- GLP1-RAs Effects on Inflammatory and Endothelial Biomarkers in T2DM
- A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
- Comparison of Body Weight Change Through Different Smeglutide Administration Methods
- Influence on the Effect of an Oral Contraceptive Drug After Administration of Liraglutide in Postmenopausal Women
- Efficacy and Safety of Insulin Glargine/ Lixisenatide Fixed Ratio Combination Compared to Insulin Glargine Alone and Lixisenatide Alone on Top of Metformin in Patients With T2DM
- A Study of Orforglipron for the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-MAINTAIN)
- A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Saudi Arabia, as Part of Local Clinical Practice
- Glycaemic Control of Monthly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes
- Exenatide Once-weekly as a Treatment for Multiple System Atrophy
- Liraglutide and Peripheral Artery Disease
- Therapeutic Effects and Effects on Body Fat of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes for 1-4 Years
- A Study to Investigate Safety and Efficacy of iGlarLixi in Adult Patients With Type 2 Diabetes Mellitus
- GLP-1 and Non-exercise Activity Thermogenesis in RHZ
- Intravenous Exenatide in Patients With Acute Brain Injury
- A Study of XW003 in Obese Participants With Obstructive Sleep Apnea But Not Receive Positive Airway Pressure Therapy
- Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
- An Exploratory Study on the Effects of Repeat Doses of Albiglutide Compared to Exenatide on Gastric Myoelectrical Activity and Gastric Emptying in Type 2 Diabetes Mellitus Subjects
- Efficacy and Safety of IBI362 in Hypertensive Patients With Overweight/Obesity
- A Study of Dulaglutide in Chinese Participants
- Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NN9924 in Healthy Male Subjects
- Investigating the Safety Profile of Liraglutide Under Normal Conditions of Use in Korean Subjects With Type 2 Diabetes Mellitus
- Influence of Semaglutide on Pharmacokinetics and Pharmacodynamics of Warfarin and Pharmacokinetics of Metformin in Healthy Subjects
- Basal Plus GLP1-ra on Glycemic Variability in CKD
- Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo in Participants Who Are Either Obese or Overweight With Weight-Related Comorbidities (SURMOUNT-1)
- Semaglutide Treatment, Appetite, and Eating Behavior: Long-term Effects
- Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin
- A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2)
- Acute Effect of Exenatide on Brain Glucose Metabolism
- Effectiveness and Safety of Semaglutide Combined With Dietary Fiber (Soloways) in Adults With Overweight or Obesity
- Translational Health Research Into Vascular and Neurocognitive Effects of Weight Loss
- RECLAIM STUDY: A Phase 2 Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol Use Disorder (AUD) in Subjects With Obesity or Overweight
- SAFEGUARD: Pleiotropic Effects of Incretin Based Therapies
- Real World Effectiveness of Combining an Employer-based Weight Management Program With Medication for Chronic Weight Management in Employees With Obesity